Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FOXA1 |
| Upstream (Parents) |
|---|
| (<<) PRR15 → FOXA1 |
| (<<) SPDEF → FOXA1 |
| Downstream (Children) |
|---|
| FOXA1 → AGR2 (>>) |
| FOXA1 → TOX3 (>>) |
| FOXA1 → CXorf61 (>>) |
| FOXA1 → TMEM135 (>>) |
| FOXA1 → TMC5 (>>) |
| FOXA1 → ZMYND8 (>>) |
| FOXA1 → FGG (>>) |
| FOXA1 → DYNLRB2 (>>) |
| FOXA1 → JKAMP (>>) |
| FOXA1 → FGB (>>) |
| FOXA1 → UGT8 (>>) |
| FOXA1 → RAB40B (>>) |
| FOXA1 → GNA14 (>>) |
| FOXA1 → LOC646360 (>>) |
| FOXA1 → GALNT10 (>>) |
| FOXA1 → KCNK5 (>>) |
| FOXA1 → TFF3 (>>) |
| FOXA1 → CADPS2 (>>) |
| FOXA1 → ANKRD30A (>>) |
| FOXA1 → CAPN13 (>>) |
| FOXA1 → TFCP2L1 (>>) |
| FOXA1 → SPDEF (>>) |
| FOXA1 → IGF2BP3 (>>) |
| FOXA1 → C3orf14 (>>) |
| FOXA1 → CHI3L1 (>>) |
| FOXA1 → FBXO31 (>>) |
| FOXA1 → HOXB6 (>>) |
| FOXA1 → TP53INP1 (>>) |
| FOXA1 → ACOX2 (>>) |
| FOXA1 → RGMA (>>) |
| FOXA1 → NAT1 (>>) |
| FOXA1 → FLJ30375 (>>) |
| FOXA1 → TAF4B (>>) |
| FOXA1 → MYC (>>) |
| FOXA1 → KIAA0485 (>>) |
| FOXA1 → GALNT7 (>>) |
| FOXA1 → PPARA (>>) |
| FOXA1 → HOXC9 (>>) |
| FOXA1 → EPB41L4A (>>) |
| FOXA1 → KIAA1370 (>>) |
| FOXA1 → SLC22A23 (>>) |
| FOXA1 → DNAJC12 (>>) |
| FOXA1 → C1orf168 (>>) |
| FOXA1 → CUEDC1 (>>) |
| FOXA1 → AR (>>) |
| FOXA1 → NMT2 (>>) |
| FOXA1 → KITLG (>>) |
| FOXA1 → TSPYL5 (>>) |
| FOXA1 → RET (>>) |
| FOXA1 → TCF7L1 (>>) |
| FOXA1 → SPOPL (>>) |
| FOXA1 → PM20D2 (>>) |
| FOXA1 → GPR98 (>>) |
| FOXA1 → INPP4B (>>) |
| FOXA1 → NFIA (>>) |
| FOXA1 → ENPP1 (>>) |
| FOXA1 → FZD4 (>>) |
| FOXA1 → ZNF350 (>>) |
